Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Company release

Nanoform Finland Plc

October 27, 2022

19:15 Finnish time / 18:15 Swedish time

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s other senior manager Niklas Sandler’s share disposal.

Person subject to the notification requirement

Name: Niklas Sandler

Position: Other senior manager

Issuer: Nanoform Finland Oyj

LEI: 743700JJO2NU8LBS1592

Notification type: INITIAL NOTIFICATION

Reference number: 20620/6/6 and 20623/4/4

Transaction date: 2022-10-26

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000330972

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 6990 Unit price: 2.6203 EUR

Aggregated transactions

(1): Volume: 6990 Volume weighted average price: 2.6203 EUR

Transaction date: 2022-10-27

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000330972

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 5010 Unit price: 2.599 EUR

Aggregated transactions

(1): Volume: 5010 Volume weighted average price: 2.599 EUR

For further information, please contact:

Peter Hänninen

General Counsel

[email protected]

+358 50 353 040

For investor relations queries, please contact:

Henri von Haartman

Director of Investor Relations

[email protected]

+46 7686 650 11

About Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 744 1900. For more information, please visit www.nanoform.com.

Bifogade filer

Nyheter om Nanoform

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Nanoform

Senaste nytt